Saturday, October 3, 2026

EUR/JPY Rises As The BoJ Will Stick To Its Dovish Stance: (EURJPY) Bearish Momentum: 0.775% Down In The Last 24 Hours

Via News Just in

July 24, 2023

EUR/JPY Rises As The BoJ Will Stick To Its Dovish Stance: (EURJPY) Bearish Momentum: 0.775% Down In The Last 24 Hours
(VIANEWS) - The EUR/JPY gained significant momentum at the end of the week amid a broad-based JPY weakness. Japanese inflation is seeing some signs of deceleration in June and reports of the Bank of Japan sticking to its dovish monetary policy in next week's meeting makes the Yen lose interest. As reported by FXStreet, june inflation data from Japan saw the National Consumer Price Index (CPI) dropping to 3.3% vs the 3.5% YoY expected, while the Core measure came in at 4.2% YoY, just as expected. That being said, the JPY is losing ground amid the speculations that the BoJ will maintain its dovish stance in next week's meeting. According to Reuters, the bank considers that inflation is increasing but is not confident if the increase is sustainable, putting a hold on a potential policy pivot. EUR/JPY (EURJPY) has been up by 0.7751% for the last session's close. At 05:07 EST on Monday, 24 July, EUR/JPY (EURJPY) is $156.56.

Eur/jpy price analysis: pulls back from multi-year peak, once again fails near 158.00 mark

This makes it prudent to wait for some follow-through buying and acceptance above the 158.00 mark before placing fresh bullish bets around the EUR/JPY cross. , This revives hopes that the Bank of Japan (BoJ) might tweak its Yield Curve Control (YCC) policy later this week, which, along with a softer risk tone, underpins the safe-haven JPY and exerts some pressure on the EUR/JPY cross.

EUR/JPY (EURJPY) Range

About EUR/JPY's daily highs and lows, it's 0.493% up from its trailing 24 hours low of $155.79 and 0.383% up from its trailing 24 hours high of $155.97. EUR/JPY's yearly highs and lows, it's 17.349% up from its 52-week low and 0.929% down from its 52-week high.

Volatility

EUR/JPY's last week, last month's, and last quarter's current intraday variation average was a positive 0.02%, a negative 0.02%, and a positive 0.47%, respectively. EUR/JPY's highest amplitude of average volatility was 0.20% (last week), 0.28% (last month), and 0.47% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/JPY's Forex is considered to be overbought (>=80).

Previous days news about EUR/JPY (EURJPY)

  • Eur/jpy rises to cycle highs as the boj will stick to its dovish stance. According to FXStreet on Saturday, 22 July, "The EUR/JPY gained significant momentum at the end of the week amid a broad-based JPY weakness. "
More news about EUR/JPY (EURJPY).
Via News Just in

Breaking news and real-time updates on financial markets, business developments, and economic events from Via News.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com